<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Gutierrez Guerrero | Activity</title>
	<link>https://www.catswannabecats.com/members/topattack9/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/topattack9/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Gutierrez Guerrero.</description>
	<lastBuildDate>Sun, 28 Jun 2026 07:29:42 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">58e9713733fd0106e8089d4f26e88d4c</guid>
				<title>Gutierrez Guerrero posted an update: clinicaltrials.gov (NCT02709135).



clinicaltrials.gov [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/24299/</link>
				<pubDate>Sun, 08 Jun 2025 12:10:24 -0400</pubDate>

									<content:encoded><![CDATA[<p>clinicaltrials.gov (NCT02709135).</p>
<p>clinicaltrials.gov (NCT02709135).Evaluations of replacement heifers in intensively managed grazing systems in tropical conditions are warranted. Thus, we aimed to evaluate performance, muscle and mammary gland development, oocyte quality, and in vitro production of embryos of crossbred heifers grazing an&hellip;<span class="activity-read-more" id="activity-read-more-24299"><a href="https://www.catswannabecats.com/activity/p/24299/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">33280d3553730cf3718db0e1a4e21541</guid>
				<title>Gutierrez Guerrero posted an update: To evaluate the safety and efficacy of reduced fluence CXL [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/21007/</link>
				<pubDate>Fri, 06 Jun 2025 12:23:50 -0400</pubDate>

									<content:encoded><![CDATA[<p>To evaluate the safety and efficacy of reduced fluence CXL (lower dose of UV-A irradiation) in mild to moderate keratoconus.</p>
<p> Farabi Eye Hospital, Tehran, Iran.</p>
<p> Non-randomized prospective comparative interventional case series. Every eligible patient included in the study (mild to moderate progressive keratoconus) was randomly&hellip;<span class="activity-read-more" id="activity-read-more-21007"><a href="https://www.catswannabecats.com/activity/p/21007/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">b5be0739190038d6c4b2a9a3a97f030d</guid>
				<title>Gutierrez Guerrero posted an update: To evaluate the safety and efficacy of reduced fluence CXL [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/20921/</link>
				<pubDate>Fri, 06 Jun 2025 12:06:29 -0400</pubDate>

									<content:encoded><![CDATA[<p>To evaluate the safety and efficacy of reduced fluence CXL (lower dose of UV-A irradiation) in mild to moderate keratoconus.</p>
<p> Farabi Eye Hospital, Tehran, Iran.</p>
<p> Non-randomized prospective comparative interventional case series. Every eligible patient included in the study (mild to moderate progressive keratoconus) was randomly&hellip;<span class="activity-read-more" id="activity-read-more-20921"><a href="https://www.catswannabecats.com/activity/p/20921/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">7ec6d8ffb73f6e14305b3f1b0b8124d4</guid>
				<title>Gutierrez Guerrero posted an update: CONCLUSIONS Overall, our tumor model recapitulates clinical [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/20055/</link>
				<pubDate>Thu, 05 Jun 2025 11:10:21 -0400</pubDate>

									<content:encoded><![CDATA[<p>CONCLUSIONS Overall, our tumor model recapitulates clinical peritoneal HGSC metastasis, which makes it ideal for preclinical drug screening, testing of immunotherapy-based therapeutics and studying of the tumor biology of peritoneal carcinomatosis. © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See&hellip;<span class="activity-read-more" id="activity-read-more-20055"><a href="https://www.catswannabecats.com/activity/p/20055/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">05b171c58f3438e1cb44c31ebe4e2675</guid>
				<title>Gutierrez Guerrero posted an update: Exogenous addition of paerucumarin resumed the expression of [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/3490/</link>
				<pubDate>Sat, 31 May 2025 10:45:45 -0400</pubDate>

									<content:encoded><![CDATA[<p>Exogenous addition of paerucumarin resumed the expression of mexT and mexEF-oprN genes as well as resistance against chloramphenicol and ciprofloxacin in PW4832 strain. This is a novel finding linking pvcB gene of P. aeruginosa with chloramphenicol and ciprofloxacin resistance and MexEF-OprN pump modulation which needs to be further explored.&hellip;<span class="activity-read-more" id="activity-read-more-3490"><a href="https://www.catswannabecats.com/activity/p/3490/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">8a19ed0f4fa71d1fe9968a854a9e4f0d</guid>
				<title>Gutierrez Guerrero became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/3366/</link>
				<pubDate>Sat, 31 May 2025 10:36:13 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>